ArticleThe Korean journal of pain2025
Ratio of excitatory and inhibitory synaptic processes in periaqueductal gray matter of the brain activated by the raphe magnus nucleus in a model of Parkinson's disease with hydrocortisone protection.
Article in The Korean journal of pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The involvement of antinociceptive centers in neurodegeneration within the brain, particularly in Parkinson's disease (PD), which is accompanied by chronic pain, is not yet well understood. Methods: Electrophysiological recordings were conducted on 15 king albino rats across three experimental conditions: intact, a rotenone-induced PD model, and a PD model treated with hydrocortisone. Extracellular spike activity was recorded from 241 single neurons in the periaqueductal gray (PAG) in response to stimulation of the raphe magnus nucleus (RMG). Results: The PD model exhibited significant excitotoxicity in the recorded neurons, indicative of substantial neurodegeneration, which appeared to precede both depressor (tetanic depression [TD], post-tetanic depression [PTD]) and excitatory (tetanic potentiation [TP], post-tetanic potentiation [PTP]) post-stimulus effects. A mathematical analysis of pre- and post-stimulus activation frequencies revealed the following: in the PD model with hydrocortisone protection, compared to the unprotected PD model, the pre-stimulus activation frequency of PAG neurons during high-frequency stimulation of the RMG was reduced, bringing the values closer to normal levels. The post-stimulus activation frequency of PAG neurons in the treatment group also decreased, both in depressor (TD, PTD) and excitatory (TP, PTP) responses, approaching normal levels. Conclusions: These findings, in conjunction with the previous research on the protective role of hydrocortisone in depressive reactions, suggest that hydrocortisone effectively mitigates excitotoxicity and provides significant neuroprotection in the context of PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.